- Home
- CMMB vs SGLY Comparison
CMMB vs SGLY Comparison
Compare CMMB & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- SGLY
- Stock Information
- Founded
- CMMB 2004
- SGLY 2001
- Country
- CMMB Israel
- SGLY United States
- Employees
- CMMB N/A
- SGLY N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- SGLY
- Sector
- CMMB Health Care
- SGLY
- Exchange
- CMMB Nasdaq
- SGLY Nasdaq
- Market Cap
- CMMB 13.7M
- SGLY 3.4M
- IPO Year
- CMMB N/A
- SGLY 2008
- Fundamental
- Price
- CMMB $3.23
- SGLY $0.67
- Analyst Decision
- CMMB Strong Buy
- SGLY
- Analyst Count
- CMMB 2
- SGLY 0
- Target Price
- CMMB $26.50
- SGLY N/A
- AVG Volume (30 Days)
- CMMB 270.0K
- SGLY 314.3K
- Earning Date
- CMMB 11-13-2025
- SGLY 10-14-2025
- Dividend Yield
- CMMB N/A
- SGLY N/A
- EPS Growth
- CMMB N/A
- SGLY N/A
- EPS
- CMMB N/A
- SGLY N/A
- Revenue
- CMMB N/A
- SGLY $1,813,193.00
- Revenue This Year
- CMMB N/A
- SGLY N/A
- Revenue Next Year
- CMMB N/A
- SGLY N/A
- P/E Ratio
- CMMB N/A
- SGLY N/A
- Revenue Growth
- CMMB N/A
- SGLY N/A
- 52 Week Low
- CMMB $2.39
- SGLY $0.54
- 52 Week High
- CMMB $9.84
- SGLY $5.49
- Technical
- Relative Strength Index (RSI)
- CMMB 51.76
- SGLY 36.28
- Support Level
- CMMB $3.01
- SGLY $0.71
- Resistance Level
- CMMB $3.29
- SGLY $0.85
- Average True Range (ATR)
- CMMB 0.26
- SGLY 0.06
- MACD
- CMMB -0.05
- SGLY 0.00
- Stochastic Oscillator
- CMMB 47.44
- SGLY 20.19
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.